CARDIOVASC DIABETOL 润色咨询

Cardiovascular Diabetology

出版年份:2002 年文章数:1354 投稿命中率: 开通期刊会员,数据随心看

出版周期:Irregular 自引率:28.0% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1222896, encodeId=fee3122289668, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:糖尿病<br>经验分享:想问一下 从接受到见刊 再到sci收录 大概要多长时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2511, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=967b2419476, createdName=138*****882<手机用户>9442, createdTime=Fri May 27 23:50:32 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113542, encodeId=c5a921135427d, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:内分泌<br>经验分享:希望今年IF能破10啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=301, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230208/4599f92647c84b469b139f6bf5fa7d1e/523a898550c74e6b92500c9b789a1bf1.jpg, createdBy=ecc52539451, createdName=jaimewang, createdTime=Tue Feb 07 22:22:39 CST 2023, time=2023-02-07, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2099530, encodeId=7a782099530ce, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:心血管;糖尿病<br>经验分享:杂志效率很高,投稿到录用一个月内,外审意见很专业,统计分析要求比较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=552, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epppOIrNy2qINgw0MtwMndODj7SAwAxm5LjuR7Dvtaa0TvghVBPeCTOWaHTTnvodLk91H97LzuPibg/132, createdBy=ff912327695, createdName=木帆, createdTime=Thu Nov 10 01:08:02 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970814, encodeId=23bd9e081415, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:心血管;糖尿病<br>经验分享:2月底投的,3月底一审,5月底修回,6月初通知accepted。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3916, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=998d5094007, createdName=145dc5e9m77暂无昵称, createdTime=Fri Jun 04 10:20:29 CST 2021, time=2021-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101306, encodeId=d35011013065a, content=关键词最多不能超过多少个?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3278, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101305, encodeId=44e511013053e, content=关键词筛选有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3322, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803430, encodeId=91128034308d, content=偏重的研究方向:心血管;代谢综合征<br>经验分享:想请教一下,7月6日投稿,到现在状态还是New Submission?这样正常么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4086, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=649a2623893, createdName=jingziwei1988, createdTime=Mon Jul 20 08:25:54 CST 2020, time=2020-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=524772, encodeId=ebfc524e72c2, content=你好!请教一下,单纯细胞实验没有动物实验的话,这个杂志容易接收吗?机制做的不是特别深。大概有6个figure<span class="quote">niniya731 2016-03-24 发表::<br>审稿时间:约1个月 1月6号投稿,1月25号一审补实验,3月22日修回,3月24日接收,3月24日通知交版面费。效率还是挺高的</span>, beContent=niniya731 2016-03-24 发表:: 审稿时间:约1个月 1月6号投稿,1月25号一审补实验,3月22日修回,3月24日接收,3月24日通知交版面费。效率还是挺高的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3532, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/E4tbvHd0KPJhXF8FOcuUS407Pz7C6U6rRQw4GJVmESTNUe8gRNjjQSvJUqf0JR9A8ElkhXbQtG7D2VTicrricvcK3MQYG3vWmJ/0, createdBy=d7be1616478, createdName=camille2015, createdTime=Thu Jul 14 11:43:00 CST 2016, time=2016-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531940, encodeId=c2ed531940be, content=你好,请问你的文章投了吗?<span class="quote">camille2015 2016-07-14 发表::<br>你好!请教一下,单纯细胞实验没有动物实验的话,这个杂志容易接收吗?机制做的不是特别深。大概有6个figure</span>, beContent=camille2015 2016-07-14 发表:: 你好!请教一下,单纯细胞实验没有动物实验的话,这个杂志容易接收吗?机制做的不是特别深。大概有6个figure, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3335, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63891995598, createdName=Dada1374, createdTime=Mon Jan 16 19:29:00 CST 2017, time=2017-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547356, encodeId=c1e454e35640, content=你的文章接受了吗.我也投了.好紧张.希望不被拒<span class="quote">yushanshan1988_31907528 2017-08-27 发表::<br>接收率:约50% 审稿时间:约1个月 这个杂志审稿速度和出版速度都很快.一共是两个审稿人.给出的意见都很中肯!很好的杂志!</span><span class="quote">yushanshan1988_31907528 2017-08-27 23:16:00 发表:<br>这个杂志审稿速度和出版速度都很快.一共是两个审稿人.给出的意见都很中肯!很好的杂志!</span>, beContent=yushanshan1988_31907528 2017-08-27 发表:: 接收率:约50% 审稿时间:约1个月 这个杂志审稿速度和出版速度都很快.一共是两个审稿人.给出的意见都很中肯!很好的杂志!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2607, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/31/fa0a95c1516650f0c6b2b3d5ac04a493.jpg, createdBy=65911695553, createdName=ykioradist, createdTime=Tue Sep 19 00:00:00 CST 2017, time=2017-09-19, status=1, ipAttribution=)]
    2022-05-27 138*****882<手机用户>9442

    审稿速度:3.0 | 投稿命中率:50.0
    偏重的研究方向:糖尿病
    经验分享:想问一下 从接受到见刊 再到sci收录 大概要多长时间

    4

    展开4条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1222896, encodeId=fee3122289668, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:糖尿病<br>经验分享:想问一下 从接受到见刊 再到sci收录 大概要多长时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2511, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=967b2419476, createdName=138*****882<手机用户>9442, createdTime=Fri May 27 23:50:32 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113542, encodeId=c5a921135427d, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:内分泌<br>经验分享:希望今年IF能破10啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=301, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230208/4599f92647c84b469b139f6bf5fa7d1e/523a898550c74e6b92500c9b789a1bf1.jpg, createdBy=ecc52539451, createdName=jaimewang, createdTime=Tue Feb 07 22:22:39 CST 2023, time=2023-02-07, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2099530, encodeId=7a782099530ce, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:心血管;糖尿病<br>经验分享:杂志效率很高,投稿到录用一个月内,外审意见很专业,统计分析要求比较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=552, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epppOIrNy2qINgw0MtwMndODj7SAwAxm5LjuR7Dvtaa0TvghVBPeCTOWaHTTnvodLk91H97LzuPibg/132, createdBy=ff912327695, createdName=木帆, createdTime=Thu Nov 10 01:08:02 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970814, encodeId=23bd9e081415, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:心血管;糖尿病<br>经验分享:2月底投的,3月底一审,5月底修回,6月初通知accepted。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3916, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=998d5094007, createdName=145dc5e9m77暂无昵称, createdTime=Fri Jun 04 10:20:29 CST 2021, time=2021-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101306, encodeId=d35011013065a, content=关键词最多不能超过多少个?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3278, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101305, encodeId=44e511013053e, content=关键词筛选有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3322, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803430, encodeId=91128034308d, content=偏重的研究方向:心血管;代谢综合征<br>经验分享:想请教一下,7月6日投稿,到现在状态还是New Submission?这样正常么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4086, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=649a2623893, createdName=jingziwei1988, createdTime=Mon Jul 20 08:25:54 CST 2020, time=2020-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=524772, encodeId=ebfc524e72c2, content=你好!请教一下,单纯细胞实验没有动物实验的话,这个杂志容易接收吗?机制做的不是特别深。大概有6个figure<span class="quote">niniya731 2016-03-24 发表::<br>审稿时间:约1个月 1月6号投稿,1月25号一审补实验,3月22日修回,3月24日接收,3月24日通知交版面费。效率还是挺高的</span>, beContent=niniya731 2016-03-24 发表:: 审稿时间:约1个月 1月6号投稿,1月25号一审补实验,3月22日修回,3月24日接收,3月24日通知交版面费。效率还是挺高的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3532, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/E4tbvHd0KPJhXF8FOcuUS407Pz7C6U6rRQw4GJVmESTNUe8gRNjjQSvJUqf0JR9A8ElkhXbQtG7D2VTicrricvcK3MQYG3vWmJ/0, createdBy=d7be1616478, createdName=camille2015, createdTime=Thu Jul 14 11:43:00 CST 2016, time=2016-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531940, encodeId=c2ed531940be, content=你好,请问你的文章投了吗?<span class="quote">camille2015 2016-07-14 发表::<br>你好!请教一下,单纯细胞实验没有动物实验的话,这个杂志容易接收吗?机制做的不是特别深。大概有6个figure</span>, beContent=camille2015 2016-07-14 发表:: 你好!请教一下,单纯细胞实验没有动物实验的话,这个杂志容易接收吗?机制做的不是特别深。大概有6个figure, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3335, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63891995598, createdName=Dada1374, createdTime=Mon Jan 16 19:29:00 CST 2017, time=2017-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547356, encodeId=c1e454e35640, content=你的文章接受了吗.我也投了.好紧张.希望不被拒<span class="quote">yushanshan1988_31907528 2017-08-27 发表::<br>接收率:约50% 审稿时间:约1个月 这个杂志审稿速度和出版速度都很快.一共是两个审稿人.给出的意见都很中肯!很好的杂志!</span><span class="quote">yushanshan1988_31907528 2017-08-27 23:16:00 发表:<br>这个杂志审稿速度和出版速度都很快.一共是两个审稿人.给出的意见都很中肯!很好的杂志!</span>, beContent=yushanshan1988_31907528 2017-08-27 发表:: 接收率:约50% 审稿时间:约1个月 这个杂志审稿速度和出版速度都很快.一共是两个审稿人.给出的意见都很中肯!很好的杂志!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2607, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/31/fa0a95c1516650f0c6b2b3d5ac04a493.jpg, createdBy=65911695553, createdName=ykioradist, createdTime=Tue Sep 19 00:00:00 CST 2017, time=2017-09-19, status=1, ipAttribution=)]
    2023-02-07 jaimewang 来自山西省

    审稿速度:6.0 | 投稿命中率:50.0
    偏重的研究方向:内分泌
    经验分享:希望今年IF能破10啊

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1222896, encodeId=fee3122289668, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:糖尿病<br>经验分享:想问一下 从接受到见刊 再到sci收录 大概要多长时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2511, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=967b2419476, createdName=138*****882<手机用户>9442, createdTime=Fri May 27 23:50:32 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113542, encodeId=c5a921135427d, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:内分泌<br>经验分享:希望今年IF能破10啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=301, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230208/4599f92647c84b469b139f6bf5fa7d1e/523a898550c74e6b92500c9b789a1bf1.jpg, createdBy=ecc52539451, createdName=jaimewang, createdTime=Tue Feb 07 22:22:39 CST 2023, time=2023-02-07, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2099530, encodeId=7a782099530ce, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:心血管;糖尿病<br>经验分享:杂志效率很高,投稿到录用一个月内,外审意见很专业,统计分析要求比较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=552, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epppOIrNy2qINgw0MtwMndODj7SAwAxm5LjuR7Dvtaa0TvghVBPeCTOWaHTTnvodLk91H97LzuPibg/132, createdBy=ff912327695, createdName=木帆, createdTime=Thu Nov 10 01:08:02 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970814, encodeId=23bd9e081415, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:心血管;糖尿病<br>经验分享:2月底投的,3月底一审,5月底修回,6月初通知accepted。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3916, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=998d5094007, createdName=145dc5e9m77暂无昵称, createdTime=Fri Jun 04 10:20:29 CST 2021, time=2021-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101306, encodeId=d35011013065a, content=关键词最多不能超过多少个?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3278, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101305, encodeId=44e511013053e, content=关键词筛选有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3322, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803430, encodeId=91128034308d, content=偏重的研究方向:心血管;代谢综合征<br>经验分享:想请教一下,7月6日投稿,到现在状态还是New Submission?这样正常么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4086, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=649a2623893, createdName=jingziwei1988, createdTime=Mon Jul 20 08:25:54 CST 2020, time=2020-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=524772, encodeId=ebfc524e72c2, content=你好!请教一下,单纯细胞实验没有动物实验的话,这个杂志容易接收吗?机制做的不是特别深。大概有6个figure<span class="quote">niniya731 2016-03-24 发表::<br>审稿时间:约1个月 1月6号投稿,1月25号一审补实验,3月22日修回,3月24日接收,3月24日通知交版面费。效率还是挺高的</span>, beContent=niniya731 2016-03-24 发表:: 审稿时间:约1个月 1月6号投稿,1月25号一审补实验,3月22日修回,3月24日接收,3月24日通知交版面费。效率还是挺高的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3532, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/E4tbvHd0KPJhXF8FOcuUS407Pz7C6U6rRQw4GJVmESTNUe8gRNjjQSvJUqf0JR9A8ElkhXbQtG7D2VTicrricvcK3MQYG3vWmJ/0, createdBy=d7be1616478, createdName=camille2015, createdTime=Thu Jul 14 11:43:00 CST 2016, time=2016-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531940, encodeId=c2ed531940be, content=你好,请问你的文章投了吗?<span class="quote">camille2015 2016-07-14 发表::<br>你好!请教一下,单纯细胞实验没有动物实验的话,这个杂志容易接收吗?机制做的不是特别深。大概有6个figure</span>, beContent=camille2015 2016-07-14 发表:: 你好!请教一下,单纯细胞实验没有动物实验的话,这个杂志容易接收吗?机制做的不是特别深。大概有6个figure, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3335, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63891995598, createdName=Dada1374, createdTime=Mon Jan 16 19:29:00 CST 2017, time=2017-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547356, encodeId=c1e454e35640, content=你的文章接受了吗.我也投了.好紧张.希望不被拒<span class="quote">yushanshan1988_31907528 2017-08-27 发表::<br>接收率:约50% 审稿时间:约1个月 这个杂志审稿速度和出版速度都很快.一共是两个审稿人.给出的意见都很中肯!很好的杂志!</span><span class="quote">yushanshan1988_31907528 2017-08-27 23:16:00 发表:<br>这个杂志审稿速度和出版速度都很快.一共是两个审稿人.给出的意见都很中肯!很好的杂志!</span>, beContent=yushanshan1988_31907528 2017-08-27 发表:: 接收率:约50% 审稿时间:约1个月 这个杂志审稿速度和出版速度都很快.一共是两个审稿人.给出的意见都很中肯!很好的杂志!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2607, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/31/fa0a95c1516650f0c6b2b3d5ac04a493.jpg, createdBy=65911695553, createdName=ykioradist, createdTime=Tue Sep 19 00:00:00 CST 2017, time=2017-09-19, status=1, ipAttribution=)]
    2022-11-10 木帆

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向:心血管;糖尿病
    经验分享:杂志效率很高,投稿到录用一个月内,外审意见很专业,统计分析要求比较高

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1222896, encodeId=fee3122289668, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:糖尿病<br>经验分享:想问一下 从接受到见刊 再到sci收录 大概要多长时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2511, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=967b2419476, createdName=138*****882<手机用户>9442, createdTime=Fri May 27 23:50:32 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113542, encodeId=c5a921135427d, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:内分泌<br>经验分享:希望今年IF能破10啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=301, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230208/4599f92647c84b469b139f6bf5fa7d1e/523a898550c74e6b92500c9b789a1bf1.jpg, createdBy=ecc52539451, createdName=jaimewang, createdTime=Tue Feb 07 22:22:39 CST 2023, time=2023-02-07, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2099530, encodeId=7a782099530ce, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:心血管;糖尿病<br>经验分享:杂志效率很高,投稿到录用一个月内,外审意见很专业,统计分析要求比较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=552, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epppOIrNy2qINgw0MtwMndODj7SAwAxm5LjuR7Dvtaa0TvghVBPeCTOWaHTTnvodLk91H97LzuPibg/132, createdBy=ff912327695, createdName=木帆, createdTime=Thu Nov 10 01:08:02 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970814, encodeId=23bd9e081415, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:心血管;糖尿病<br>经验分享:2月底投的,3月底一审,5月底修回,6月初通知accepted。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3916, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=998d5094007, createdName=145dc5e9m77暂无昵称, createdTime=Fri Jun 04 10:20:29 CST 2021, time=2021-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101306, encodeId=d35011013065a, content=关键词最多不能超过多少个?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3278, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101305, encodeId=44e511013053e, content=关键词筛选有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3322, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803430, encodeId=91128034308d, content=偏重的研究方向:心血管;代谢综合征<br>经验分享:想请教一下,7月6日投稿,到现在状态还是New Submission?这样正常么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4086, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=649a2623893, createdName=jingziwei1988, createdTime=Mon Jul 20 08:25:54 CST 2020, time=2020-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=524772, encodeId=ebfc524e72c2, content=你好!请教一下,单纯细胞实验没有动物实验的话,这个杂志容易接收吗?机制做的不是特别深。大概有6个figure<span class="quote">niniya731 2016-03-24 发表::<br>审稿时间:约1个月 1月6号投稿,1月25号一审补实验,3月22日修回,3月24日接收,3月24日通知交版面费。效率还是挺高的</span>, beContent=niniya731 2016-03-24 发表:: 审稿时间:约1个月 1月6号投稿,1月25号一审补实验,3月22日修回,3月24日接收,3月24日通知交版面费。效率还是挺高的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3532, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/E4tbvHd0KPJhXF8FOcuUS407Pz7C6U6rRQw4GJVmESTNUe8gRNjjQSvJUqf0JR9A8ElkhXbQtG7D2VTicrricvcK3MQYG3vWmJ/0, createdBy=d7be1616478, createdName=camille2015, createdTime=Thu Jul 14 11:43:00 CST 2016, time=2016-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531940, encodeId=c2ed531940be, content=你好,请问你的文章投了吗?<span class="quote">camille2015 2016-07-14 发表::<br>你好!请教一下,单纯细胞实验没有动物实验的话,这个杂志容易接收吗?机制做的不是特别深。大概有6个figure</span>, beContent=camille2015 2016-07-14 发表:: 你好!请教一下,单纯细胞实验没有动物实验的话,这个杂志容易接收吗?机制做的不是特别深。大概有6个figure, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3335, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63891995598, createdName=Dada1374, createdTime=Mon Jan 16 19:29:00 CST 2017, time=2017-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547356, encodeId=c1e454e35640, content=你的文章接受了吗.我也投了.好紧张.希望不被拒<span class="quote">yushanshan1988_31907528 2017-08-27 发表::<br>接收率:约50% 审稿时间:约1个月 这个杂志审稿速度和出版速度都很快.一共是两个审稿人.给出的意见都很中肯!很好的杂志!</span><span class="quote">yushanshan1988_31907528 2017-08-27 23:16:00 发表:<br>这个杂志审稿速度和出版速度都很快.一共是两个审稿人.给出的意见都很中肯!很好的杂志!</span>, beContent=yushanshan1988_31907528 2017-08-27 发表:: 接收率:约50% 审稿时间:约1个月 这个杂志审稿速度和出版速度都很快.一共是两个审稿人.给出的意见都很中肯!很好的杂志!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2607, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/31/fa0a95c1516650f0c6b2b3d5ac04a493.jpg, createdBy=65911695553, createdName=ykioradist, createdTime=Tue Sep 19 00:00:00 CST 2017, time=2017-09-19, status=1, ipAttribution=)]
    2021-06-04 145dc5e9m77暂无昵称

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向:心血管;糖尿病
    经验分享:2月底投的,3月底一审,5月底修回,6月初通知accepted。

    3

    展开3条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=1222896, encodeId=fee3122289668, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:糖尿病<br>经验分享:想问一下 从接受到见刊 再到sci收录 大概要多长时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2511, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=967b2419476, createdName=138*****882<手机用户>9442, createdTime=Fri May 27 23:50:32 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113542, encodeId=c5a921135427d, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:内分泌<br>经验分享:希望今年IF能破10啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=301, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230208/4599f92647c84b469b139f6bf5fa7d1e/523a898550c74e6b92500c9b789a1bf1.jpg, createdBy=ecc52539451, createdName=jaimewang, createdTime=Tue Feb 07 22:22:39 CST 2023, time=2023-02-07, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2099530, encodeId=7a782099530ce, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:心血管;糖尿病<br>经验分享:杂志效率很高,投稿到录用一个月内,外审意见很专业,统计分析要求比较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=552, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epppOIrNy2qINgw0MtwMndODj7SAwAxm5LjuR7Dvtaa0TvghVBPeCTOWaHTTnvodLk91H97LzuPibg/132, createdBy=ff912327695, createdName=木帆, createdTime=Thu Nov 10 01:08:02 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970814, encodeId=23bd9e081415, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:心血管;糖尿病<br>经验分享:2月底投的,3月底一审,5月底修回,6月初通知accepted。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3916, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=998d5094007, createdName=145dc5e9m77暂无昵称, createdTime=Fri Jun 04 10:20:29 CST 2021, time=2021-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101306, encodeId=d35011013065a, content=关键词最多不能超过多少个?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3278, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101305, encodeId=44e511013053e, content=关键词筛选有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3322, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803430, encodeId=91128034308d, content=偏重的研究方向:心血管;代谢综合征<br>经验分享:想请教一下,7月6日投稿,到现在状态还是New Submission?这样正常么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4086, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=649a2623893, createdName=jingziwei1988, createdTime=Mon Jul 20 08:25:54 CST 2020, time=2020-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=524772, encodeId=ebfc524e72c2, content=你好!请教一下,单纯细胞实验没有动物实验的话,这个杂志容易接收吗?机制做的不是特别深。大概有6个figure<span class="quote">niniya731 2016-03-24 发表::<br>审稿时间:约1个月 1月6号投稿,1月25号一审补实验,3月22日修回,3月24日接收,3月24日通知交版面费。效率还是挺高的</span>, beContent=niniya731 2016-03-24 发表:: 审稿时间:约1个月 1月6号投稿,1月25号一审补实验,3月22日修回,3月24日接收,3月24日通知交版面费。效率还是挺高的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3532, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/E4tbvHd0KPJhXF8FOcuUS407Pz7C6U6rRQw4GJVmESTNUe8gRNjjQSvJUqf0JR9A8ElkhXbQtG7D2VTicrricvcK3MQYG3vWmJ/0, createdBy=d7be1616478, createdName=camille2015, createdTime=Thu Jul 14 11:43:00 CST 2016, time=2016-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531940, encodeId=c2ed531940be, content=你好,请问你的文章投了吗?<span class="quote">camille2015 2016-07-14 发表::<br>你好!请教一下,单纯细胞实验没有动物实验的话,这个杂志容易接收吗?机制做的不是特别深。大概有6个figure</span>, beContent=camille2015 2016-07-14 发表:: 你好!请教一下,单纯细胞实验没有动物实验的话,这个杂志容易接收吗?机制做的不是特别深。大概有6个figure, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3335, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63891995598, createdName=Dada1374, createdTime=Mon Jan 16 19:29:00 CST 2017, time=2017-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547356, encodeId=c1e454e35640, content=你的文章接受了吗.我也投了.好紧张.希望不被拒<span class="quote">yushanshan1988_31907528 2017-08-27 发表::<br>接收率:约50% 审稿时间:约1个月 这个杂志审稿速度和出版速度都很快.一共是两个审稿人.给出的意见都很中肯!很好的杂志!</span><span class="quote">yushanshan1988_31907528 2017-08-27 23:16:00 发表:<br>这个杂志审稿速度和出版速度都很快.一共是两个审稿人.给出的意见都很中肯!很好的杂志!</span>, beContent=yushanshan1988_31907528 2017-08-27 发表:: 接收率:约50% 审稿时间:约1个月 这个杂志审稿速度和出版速度都很快.一共是两个审稿人.给出的意见都很中肯!很好的杂志!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2607, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/31/fa0a95c1516650f0c6b2b3d5ac04a493.jpg, createdBy=65911695553, createdName=ykioradist, createdTime=Tue Sep 19 00:00:00 CST 2017, time=2017-09-19, status=1, ipAttribution=)]
    2021-12-29 MS54455111222

    关键词最多不能超过多少个?

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=1222896, encodeId=fee3122289668, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:糖尿病<br>经验分享:想问一下 从接受到见刊 再到sci收录 大概要多长时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2511, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=967b2419476, createdName=138*****882<手机用户>9442, createdTime=Fri May 27 23:50:32 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113542, encodeId=c5a921135427d, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:内分泌<br>经验分享:希望今年IF能破10啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=301, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230208/4599f92647c84b469b139f6bf5fa7d1e/523a898550c74e6b92500c9b789a1bf1.jpg, createdBy=ecc52539451, createdName=jaimewang, createdTime=Tue Feb 07 22:22:39 CST 2023, time=2023-02-07, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2099530, encodeId=7a782099530ce, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:心血管;糖尿病<br>经验分享:杂志效率很高,投稿到录用一个月内,外审意见很专业,统计分析要求比较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=552, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epppOIrNy2qINgw0MtwMndODj7SAwAxm5LjuR7Dvtaa0TvghVBPeCTOWaHTTnvodLk91H97LzuPibg/132, createdBy=ff912327695, createdName=木帆, createdTime=Thu Nov 10 01:08:02 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970814, encodeId=23bd9e081415, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:心血管;糖尿病<br>经验分享:2月底投的,3月底一审,5月底修回,6月初通知accepted。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3916, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=998d5094007, createdName=145dc5e9m77暂无昵称, createdTime=Fri Jun 04 10:20:29 CST 2021, time=2021-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101306, encodeId=d35011013065a, content=关键词最多不能超过多少个?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3278, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101305, encodeId=44e511013053e, content=关键词筛选有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3322, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803430, encodeId=91128034308d, content=偏重的研究方向:心血管;代谢综合征<br>经验分享:想请教一下,7月6日投稿,到现在状态还是New Submission?这样正常么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4086, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=649a2623893, createdName=jingziwei1988, createdTime=Mon Jul 20 08:25:54 CST 2020, time=2020-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=524772, encodeId=ebfc524e72c2, content=你好!请教一下,单纯细胞实验没有动物实验的话,这个杂志容易接收吗?机制做的不是特别深。大概有6个figure<span class="quote">niniya731 2016-03-24 发表::<br>审稿时间:约1个月 1月6号投稿,1月25号一审补实验,3月22日修回,3月24日接收,3月24日通知交版面费。效率还是挺高的</span>, beContent=niniya731 2016-03-24 发表:: 审稿时间:约1个月 1月6号投稿,1月25号一审补实验,3月22日修回,3月24日接收,3月24日通知交版面费。效率还是挺高的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3532, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/E4tbvHd0KPJhXF8FOcuUS407Pz7C6U6rRQw4GJVmESTNUe8gRNjjQSvJUqf0JR9A8ElkhXbQtG7D2VTicrricvcK3MQYG3vWmJ/0, createdBy=d7be1616478, createdName=camille2015, createdTime=Thu Jul 14 11:43:00 CST 2016, time=2016-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531940, encodeId=c2ed531940be, content=你好,请问你的文章投了吗?<span class="quote">camille2015 2016-07-14 发表::<br>你好!请教一下,单纯细胞实验没有动物实验的话,这个杂志容易接收吗?机制做的不是特别深。大概有6个figure</span>, beContent=camille2015 2016-07-14 发表:: 你好!请教一下,单纯细胞实验没有动物实验的话,这个杂志容易接收吗?机制做的不是特别深。大概有6个figure, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3335, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63891995598, createdName=Dada1374, createdTime=Mon Jan 16 19:29:00 CST 2017, time=2017-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547356, encodeId=c1e454e35640, content=你的文章接受了吗.我也投了.好紧张.希望不被拒<span class="quote">yushanshan1988_31907528 2017-08-27 发表::<br>接收率:约50% 审稿时间:约1个月 这个杂志审稿速度和出版速度都很快.一共是两个审稿人.给出的意见都很中肯!很好的杂志!</span><span class="quote">yushanshan1988_31907528 2017-08-27 23:16:00 发表:<br>这个杂志审稿速度和出版速度都很快.一共是两个审稿人.给出的意见都很中肯!很好的杂志!</span>, beContent=yushanshan1988_31907528 2017-08-27 发表:: 接收率:约50% 审稿时间:约1个月 这个杂志审稿速度和出版速度都很快.一共是两个审稿人.给出的意见都很中肯!很好的杂志!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2607, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/31/fa0a95c1516650f0c6b2b3d5ac04a493.jpg, createdBy=65911695553, createdName=ykioradist, createdTime=Tue Sep 19 00:00:00 CST 2017, time=2017-09-19, status=1, ipAttribution=)]
    2021-12-29 小动量

    关键词筛选有什么要求?

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=1222896, encodeId=fee3122289668, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:糖尿病<br>经验分享:想问一下 从接受到见刊 再到sci收录 大概要多长时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2511, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=967b2419476, createdName=138*****882<手机用户>9442, createdTime=Fri May 27 23:50:32 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113542, encodeId=c5a921135427d, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:内分泌<br>经验分享:希望今年IF能破10啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=301, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230208/4599f92647c84b469b139f6bf5fa7d1e/523a898550c74e6b92500c9b789a1bf1.jpg, createdBy=ecc52539451, createdName=jaimewang, createdTime=Tue Feb 07 22:22:39 CST 2023, time=2023-02-07, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2099530, encodeId=7a782099530ce, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:心血管;糖尿病<br>经验分享:杂志效率很高,投稿到录用一个月内,外审意见很专业,统计分析要求比较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=552, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epppOIrNy2qINgw0MtwMndODj7SAwAxm5LjuR7Dvtaa0TvghVBPeCTOWaHTTnvodLk91H97LzuPibg/132, createdBy=ff912327695, createdName=木帆, createdTime=Thu Nov 10 01:08:02 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970814, encodeId=23bd9e081415, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:心血管;糖尿病<br>经验分享:2月底投的,3月底一审,5月底修回,6月初通知accepted。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3916, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=998d5094007, createdName=145dc5e9m77暂无昵称, createdTime=Fri Jun 04 10:20:29 CST 2021, time=2021-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101306, encodeId=d35011013065a, content=关键词最多不能超过多少个?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3278, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101305, encodeId=44e511013053e, content=关键词筛选有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3322, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803430, encodeId=91128034308d, content=偏重的研究方向:心血管;代谢综合征<br>经验分享:想请教一下,7月6日投稿,到现在状态还是New Submission?这样正常么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4086, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=649a2623893, createdName=jingziwei1988, createdTime=Mon Jul 20 08:25:54 CST 2020, time=2020-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=524772, encodeId=ebfc524e72c2, content=你好!请教一下,单纯细胞实验没有动物实验的话,这个杂志容易接收吗?机制做的不是特别深。大概有6个figure<span class="quote">niniya731 2016-03-24 发表::<br>审稿时间:约1个月 1月6号投稿,1月25号一审补实验,3月22日修回,3月24日接收,3月24日通知交版面费。效率还是挺高的</span>, beContent=niniya731 2016-03-24 发表:: 审稿时间:约1个月 1月6号投稿,1月25号一审补实验,3月22日修回,3月24日接收,3月24日通知交版面费。效率还是挺高的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3532, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/E4tbvHd0KPJhXF8FOcuUS407Pz7C6U6rRQw4GJVmESTNUe8gRNjjQSvJUqf0JR9A8ElkhXbQtG7D2VTicrricvcK3MQYG3vWmJ/0, createdBy=d7be1616478, createdName=camille2015, createdTime=Thu Jul 14 11:43:00 CST 2016, time=2016-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531940, encodeId=c2ed531940be, content=你好,请问你的文章投了吗?<span class="quote">camille2015 2016-07-14 发表::<br>你好!请教一下,单纯细胞实验没有动物实验的话,这个杂志容易接收吗?机制做的不是特别深。大概有6个figure</span>, beContent=camille2015 2016-07-14 发表:: 你好!请教一下,单纯细胞实验没有动物实验的话,这个杂志容易接收吗?机制做的不是特别深。大概有6个figure, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3335, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63891995598, createdName=Dada1374, createdTime=Mon Jan 16 19:29:00 CST 2017, time=2017-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547356, encodeId=c1e454e35640, content=你的文章接受了吗.我也投了.好紧张.希望不被拒<span class="quote">yushanshan1988_31907528 2017-08-27 发表::<br>接收率:约50% 审稿时间:约1个月 这个杂志审稿速度和出版速度都很快.一共是两个审稿人.给出的意见都很中肯!很好的杂志!</span><span class="quote">yushanshan1988_31907528 2017-08-27 23:16:00 发表:<br>这个杂志审稿速度和出版速度都很快.一共是两个审稿人.给出的意见都很中肯!很好的杂志!</span>, beContent=yushanshan1988_31907528 2017-08-27 发表:: 接收率:约50% 审稿时间:约1个月 这个杂志审稿速度和出版速度都很快.一共是两个审稿人.给出的意见都很中肯!很好的杂志!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2607, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/31/fa0a95c1516650f0c6b2b3d5ac04a493.jpg, createdBy=65911695553, createdName=ykioradist, createdTime=Tue Sep 19 00:00:00 CST 2017, time=2017-09-19, status=1, ipAttribution=)]
    2020-07-20 jingziwei1988

    偏重的研究方向:心血管;代谢综合征
    经验分享:想请教一下,7月6日投稿,到现在状态还是New Submission?这样正常么

    3

    展开3条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=1222896, encodeId=fee3122289668, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:糖尿病<br>经验分享:想问一下 从接受到见刊 再到sci收录 大概要多长时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2511, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=967b2419476, createdName=138*****882<手机用户>9442, createdTime=Fri May 27 23:50:32 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113542, encodeId=c5a921135427d, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:内分泌<br>经验分享:希望今年IF能破10啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=301, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230208/4599f92647c84b469b139f6bf5fa7d1e/523a898550c74e6b92500c9b789a1bf1.jpg, createdBy=ecc52539451, createdName=jaimewang, createdTime=Tue Feb 07 22:22:39 CST 2023, time=2023-02-07, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2099530, encodeId=7a782099530ce, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:心血管;糖尿病<br>经验分享:杂志效率很高,投稿到录用一个月内,外审意见很专业,统计分析要求比较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=552, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epppOIrNy2qINgw0MtwMndODj7SAwAxm5LjuR7Dvtaa0TvghVBPeCTOWaHTTnvodLk91H97LzuPibg/132, createdBy=ff912327695, createdName=木帆, createdTime=Thu Nov 10 01:08:02 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970814, encodeId=23bd9e081415, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:心血管;糖尿病<br>经验分享:2月底投的,3月底一审,5月底修回,6月初通知accepted。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3916, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=998d5094007, createdName=145dc5e9m77暂无昵称, createdTime=Fri Jun 04 10:20:29 CST 2021, time=2021-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101306, encodeId=d35011013065a, content=关键词最多不能超过多少个?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3278, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101305, encodeId=44e511013053e, content=关键词筛选有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3322, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803430, encodeId=91128034308d, content=偏重的研究方向:心血管;代谢综合征<br>经验分享:想请教一下,7月6日投稿,到现在状态还是New Submission?这样正常么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4086, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=649a2623893, createdName=jingziwei1988, createdTime=Mon Jul 20 08:25:54 CST 2020, time=2020-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=524772, encodeId=ebfc524e72c2, content=你好!请教一下,单纯细胞实验没有动物实验的话,这个杂志容易接收吗?机制做的不是特别深。大概有6个figure<span class="quote">niniya731 2016-03-24 发表::<br>审稿时间:约1个月 1月6号投稿,1月25号一审补实验,3月22日修回,3月24日接收,3月24日通知交版面费。效率还是挺高的</span>, beContent=niniya731 2016-03-24 发表:: 审稿时间:约1个月 1月6号投稿,1月25号一审补实验,3月22日修回,3月24日接收,3月24日通知交版面费。效率还是挺高的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3532, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/E4tbvHd0KPJhXF8FOcuUS407Pz7C6U6rRQw4GJVmESTNUe8gRNjjQSvJUqf0JR9A8ElkhXbQtG7D2VTicrricvcK3MQYG3vWmJ/0, createdBy=d7be1616478, createdName=camille2015, createdTime=Thu Jul 14 11:43:00 CST 2016, time=2016-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531940, encodeId=c2ed531940be, content=你好,请问你的文章投了吗?<span class="quote">camille2015 2016-07-14 发表::<br>你好!请教一下,单纯细胞实验没有动物实验的话,这个杂志容易接收吗?机制做的不是特别深。大概有6个figure</span>, beContent=camille2015 2016-07-14 发表:: 你好!请教一下,单纯细胞实验没有动物实验的话,这个杂志容易接收吗?机制做的不是特别深。大概有6个figure, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3335, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63891995598, createdName=Dada1374, createdTime=Mon Jan 16 19:29:00 CST 2017, time=2017-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547356, encodeId=c1e454e35640, content=你的文章接受了吗.我也投了.好紧张.希望不被拒<span class="quote">yushanshan1988_31907528 2017-08-27 发表::<br>接收率:约50% 审稿时间:约1个月 这个杂志审稿速度和出版速度都很快.一共是两个审稿人.给出的意见都很中肯!很好的杂志!</span><span class="quote">yushanshan1988_31907528 2017-08-27 23:16:00 发表:<br>这个杂志审稿速度和出版速度都很快.一共是两个审稿人.给出的意见都很中肯!很好的杂志!</span>, beContent=yushanshan1988_31907528 2017-08-27 发表:: 接收率:约50% 审稿时间:约1个月 这个杂志审稿速度和出版速度都很快.一共是两个审稿人.给出的意见都很中肯!很好的杂志!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2607, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/31/fa0a95c1516650f0c6b2b3d5ac04a493.jpg, createdBy=65911695553, createdName=ykioradist, createdTime=Tue Sep 19 00:00:00 CST 2017, time=2017-09-19, status=1, ipAttribution=)]
    2016-07-14 camille2015

    你好!请教一下,单纯细胞实验没有动物实验的话,这个杂志容易接收吗?机制做的不是特别深。大概有6个figureniniya731 2016-03-24 发表::
    审稿时间:约1个月 1月6号投稿,1月25号一审补实验,3月22日修回,3月24日接收,3月24日通知交版面费。效率还是挺高的

    niniya731 2016-03-24 发表:: 审稿时间:约1个月 1月6号投稿,1月25号一审补实验,3月22日修回,3月24日接收,3月24日通知交版面费。效率还是挺高的

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=1222896, encodeId=fee3122289668, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:糖尿病<br>经验分享:想问一下 从接受到见刊 再到sci收录 大概要多长时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2511, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=967b2419476, createdName=138*****882<手机用户>9442, createdTime=Fri May 27 23:50:32 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113542, encodeId=c5a921135427d, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:内分泌<br>经验分享:希望今年IF能破10啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=301, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230208/4599f92647c84b469b139f6bf5fa7d1e/523a898550c74e6b92500c9b789a1bf1.jpg, createdBy=ecc52539451, createdName=jaimewang, createdTime=Tue Feb 07 22:22:39 CST 2023, time=2023-02-07, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2099530, encodeId=7a782099530ce, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:心血管;糖尿病<br>经验分享:杂志效率很高,投稿到录用一个月内,外审意见很专业,统计分析要求比较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=552, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epppOIrNy2qINgw0MtwMndODj7SAwAxm5LjuR7Dvtaa0TvghVBPeCTOWaHTTnvodLk91H97LzuPibg/132, createdBy=ff912327695, createdName=木帆, createdTime=Thu Nov 10 01:08:02 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970814, encodeId=23bd9e081415, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:心血管;糖尿病<br>经验分享:2月底投的,3月底一审,5月底修回,6月初通知accepted。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3916, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=998d5094007, createdName=145dc5e9m77暂无昵称, createdTime=Fri Jun 04 10:20:29 CST 2021, time=2021-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101306, encodeId=d35011013065a, content=关键词最多不能超过多少个?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3278, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101305, encodeId=44e511013053e, content=关键词筛选有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3322, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803430, encodeId=91128034308d, content=偏重的研究方向:心血管;代谢综合征<br>经验分享:想请教一下,7月6日投稿,到现在状态还是New Submission?这样正常么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4086, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=649a2623893, createdName=jingziwei1988, createdTime=Mon Jul 20 08:25:54 CST 2020, time=2020-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=524772, encodeId=ebfc524e72c2, content=你好!请教一下,单纯细胞实验没有动物实验的话,这个杂志容易接收吗?机制做的不是特别深。大概有6个figure<span class="quote">niniya731 2016-03-24 发表::<br>审稿时间:约1个月 1月6号投稿,1月25号一审补实验,3月22日修回,3月24日接收,3月24日通知交版面费。效率还是挺高的</span>, beContent=niniya731 2016-03-24 发表:: 审稿时间:约1个月 1月6号投稿,1月25号一审补实验,3月22日修回,3月24日接收,3月24日通知交版面费。效率还是挺高的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3532, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/E4tbvHd0KPJhXF8FOcuUS407Pz7C6U6rRQw4GJVmESTNUe8gRNjjQSvJUqf0JR9A8ElkhXbQtG7D2VTicrricvcK3MQYG3vWmJ/0, createdBy=d7be1616478, createdName=camille2015, createdTime=Thu Jul 14 11:43:00 CST 2016, time=2016-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531940, encodeId=c2ed531940be, content=你好,请问你的文章投了吗?<span class="quote">camille2015 2016-07-14 发表::<br>你好!请教一下,单纯细胞实验没有动物实验的话,这个杂志容易接收吗?机制做的不是特别深。大概有6个figure</span>, beContent=camille2015 2016-07-14 发表:: 你好!请教一下,单纯细胞实验没有动物实验的话,这个杂志容易接收吗?机制做的不是特别深。大概有6个figure, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3335, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63891995598, createdName=Dada1374, createdTime=Mon Jan 16 19:29:00 CST 2017, time=2017-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547356, encodeId=c1e454e35640, content=你的文章接受了吗.我也投了.好紧张.希望不被拒<span class="quote">yushanshan1988_31907528 2017-08-27 发表::<br>接收率:约50% 审稿时间:约1个月 这个杂志审稿速度和出版速度都很快.一共是两个审稿人.给出的意见都很中肯!很好的杂志!</span><span class="quote">yushanshan1988_31907528 2017-08-27 23:16:00 发表:<br>这个杂志审稿速度和出版速度都很快.一共是两个审稿人.给出的意见都很中肯!很好的杂志!</span>, beContent=yushanshan1988_31907528 2017-08-27 发表:: 接收率:约50% 审稿时间:约1个月 这个杂志审稿速度和出版速度都很快.一共是两个审稿人.给出的意见都很中肯!很好的杂志!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2607, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/31/fa0a95c1516650f0c6b2b3d5ac04a493.jpg, createdBy=65911695553, createdName=ykioradist, createdTime=Tue Sep 19 00:00:00 CST 2017, time=2017-09-19, status=1, ipAttribution=)]
    2017-01-16 Dada1374

    你好,请问你的文章投了吗?camille2015 2016-07-14 发表::
    你好!请教一下,单纯细胞实验没有动物实验的话,这个杂志容易接收吗?机制做的不是特别深。大概有6个figure

    camille2015 2016-07-14 发表:: 你好!请教一下,单纯细胞实验没有动物实验的话,这个杂志容易接收吗?机制做的不是特别深。大概有6个figure

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=1222896, encodeId=fee3122289668, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:糖尿病<br>经验分享:想问一下 从接受到见刊 再到sci收录 大概要多长时间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2511, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=967b2419476, createdName=138*****882<手机用户>9442, createdTime=Fri May 27 23:50:32 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2113542, encodeId=c5a921135427d, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:内分泌<br>经验分享:希望今年IF能破10啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=301, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230208/4599f92647c84b469b139f6bf5fa7d1e/523a898550c74e6b92500c9b789a1bf1.jpg, createdBy=ecc52539451, createdName=jaimewang, createdTime=Tue Feb 07 22:22:39 CST 2023, time=2023-02-07, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2099530, encodeId=7a782099530ce, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:心血管;糖尿病<br>经验分享:杂志效率很高,投稿到录用一个月内,外审意见很专业,统计分析要求比较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=552, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epppOIrNy2qINgw0MtwMndODj7SAwAxm5LjuR7Dvtaa0TvghVBPeCTOWaHTTnvodLk91H97LzuPibg/132, createdBy=ff912327695, createdName=木帆, createdTime=Thu Nov 10 01:08:02 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970814, encodeId=23bd9e081415, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:心血管;糖尿病<br>经验分享:2月底投的,3月底一审,5月底修回,6月初通知accepted。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3916, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=998d5094007, createdName=145dc5e9m77暂无昵称, createdTime=Fri Jun 04 10:20:29 CST 2021, time=2021-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101306, encodeId=d35011013065a, content=关键词最多不能超过多少个?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3278, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101305, encodeId=44e511013053e, content=关键词筛选有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3322, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803430, encodeId=91128034308d, content=偏重的研究方向:心血管;代谢综合征<br>经验分享:想请教一下,7月6日投稿,到现在状态还是New Submission?这样正常么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4086, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=649a2623893, createdName=jingziwei1988, createdTime=Mon Jul 20 08:25:54 CST 2020, time=2020-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=524772, encodeId=ebfc524e72c2, content=你好!请教一下,单纯细胞实验没有动物实验的话,这个杂志容易接收吗?机制做的不是特别深。大概有6个figure<span class="quote">niniya731 2016-03-24 发表::<br>审稿时间:约1个月 1月6号投稿,1月25号一审补实验,3月22日修回,3月24日接收,3月24日通知交版面费。效率还是挺高的</span>, beContent=niniya731 2016-03-24 发表:: 审稿时间:约1个月 1月6号投稿,1月25号一审补实验,3月22日修回,3月24日接收,3月24日通知交版面费。效率还是挺高的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3532, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/E4tbvHd0KPJhXF8FOcuUS407Pz7C6U6rRQw4GJVmESTNUe8gRNjjQSvJUqf0JR9A8ElkhXbQtG7D2VTicrricvcK3MQYG3vWmJ/0, createdBy=d7be1616478, createdName=camille2015, createdTime=Thu Jul 14 11:43:00 CST 2016, time=2016-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=531940, encodeId=c2ed531940be, content=你好,请问你的文章投了吗?<span class="quote">camille2015 2016-07-14 发表::<br>你好!请教一下,单纯细胞实验没有动物实验的话,这个杂志容易接收吗?机制做的不是特别深。大概有6个figure</span>, beContent=camille2015 2016-07-14 发表:: 你好!请教一下,单纯细胞实验没有动物实验的话,这个杂志容易接收吗?机制做的不是特别深。大概有6个figure, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3335, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63891995598, createdName=Dada1374, createdTime=Mon Jan 16 19:29:00 CST 2017, time=2017-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547356, encodeId=c1e454e35640, content=你的文章接受了吗.我也投了.好紧张.希望不被拒<span class="quote">yushanshan1988_31907528 2017-08-27 发表::<br>接收率:约50% 审稿时间:约1个月 这个杂志审稿速度和出版速度都很快.一共是两个审稿人.给出的意见都很中肯!很好的杂志!</span><span class="quote">yushanshan1988_31907528 2017-08-27 23:16:00 发表:<br>这个杂志审稿速度和出版速度都很快.一共是两个审稿人.给出的意见都很中肯!很好的杂志!</span>, beContent=yushanshan1988_31907528 2017-08-27 发表:: 接收率:约50% 审稿时间:约1个月 这个杂志审稿速度和出版速度都很快.一共是两个审稿人.给出的意见都很中肯!很好的杂志!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2607, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/05/31/fa0a95c1516650f0c6b2b3d5ac04a493.jpg, createdBy=65911695553, createdName=ykioradist, createdTime=Tue Sep 19 00:00:00 CST 2017, time=2017-09-19, status=1, ipAttribution=)]
    2017-09-19 ykioradist

    你的文章接受了吗.我也投了.好紧张.希望不被拒yushanshan1988_31907528 2017-08-27 发表::
    接收率:约50% 审稿时间:约1个月 这个杂志审稿速度和出版速度都很快.一共是两个审稿人.给出的意见都很中肯!很好的杂志!
    yushanshan1988_31907528 2017-08-27 23:16:00 发表:
    这个杂志审稿速度和出版速度都很快.一共是两个审稿人.给出的意见都很中肯!很好的杂志!

    yushanshan1988_31907528 2017-08-27 发表:: 接收率:约50% 审稿时间:约1个月 这个杂志审稿速度和出版速度都很快.一共是两个审稿人.给出的意见都很中肯!很好的杂志!

    1

    展开1条回复
共107条页码: 2/11页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分